Regression von �sophaguskarzinomen nach neoadjuvanter Radiochemotherapie

Adelstein DJ, Rice TW, Becker M et al. (1997) Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 80:1011?1020

Becker K, Fumagalli U, Mueller JD et al. (1999) Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes. Cancer 85:1484?1489

Becker K, Mueller J, Fink U et al. (2000) Morphologische Responseevaluierung beim neoadjuvant chemotherapierten Magenkarzinom. Verh Dtsch Ges Pathol 84:164?174

Bollschweiler E, Schröder W, Hölscher AH, Siewert JR (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87:1106?1110

Darnton SJ, Allen SM, Edwards CW, Matthews HR (1993) Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J Clin Pathol 46:51?55

Diez M, Ramos P, Medrano MJ et al. (2003) Preoperatively irradiated rectal carcinoma: analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining. Oncology 64:213?219

Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19?23

Esposito G, Pucciarelli S, Alaggio R et al. (2001) P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol 8:311?318

Hermann RM, Krech R, Hartlapp J et al. (2001) Wertigkeit eines qualitativen Regressionsgradings als prognostischer Faktor für das Überleben bei präoperativ radiochemotherapierten Patienten mit fortgeschrittenen Kopf-Hals-Karzinomen. Strahlenther Onkol 177:277?282

Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric cancer, 1st english edn. Kanehara, Tokyo

Junker K, Krapp D, Müller KM (1995) Kleinzelliges Bronchialkarzinom nach Chemotherapie. Pathologe 16:217?222

Junker K, Thomas M, Schulmann K et al. (1997) Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 123:469?477

Junker K, Thomas M, Schulmann K et al. (1997) Regressionsgrading neoadjuvant behandelter nichtkleinzelliger Lungenkarzinome. Pathologe 18:131?140

Junker K, Langner K, Klinke F et al. (2001) Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 120:1584?1591

Kajiyama Y, Hattori K, Tomita N et al. (2002) Histopathologic effects of neoadjuvant therapies for advanced squamous cell carcinoma of the esophagus: multivariate analysis of predictive factors and p53 overexpression. Dis Esophagus 15:61?66

Kelsen DP (2000) Multimodality therapy of esophageal cancer: an update. Cancer J 6 Suppl 2:S177?S181

Mandard AM, Dalibard F, Mandard JC et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680?2686

Masoni L, Valentino M, Passarelli F et al. (1997) Modificazioni istologiche del cancro del retto dopo radio-chemioterapia neo-adiuvante. Correlazioni anatomo-radiologiche ed implicazioni prognostiche. G Chir 18:630?636

Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359:1727?1733

Rödel C, Grabenbauer GG, Papadopoulos T et al. (2002) Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52:294?303

Satomi D, Takiguchi N, Koda K et al. (2002) Apoptosis and apoptosis-associated gene products related to the response to neoadjuvant chemotherapy for gastric cancer. Int J Oncol 20:1167?1171

Schneider PM, Zirbes TK, Metzger R et al. (1999) Histomorphologisches Regressionsgrading und Apoptose-Index als objektive Response-Parameter beim neoadjuvant chemotherapierten Adenocarcinom des Magens und ösophagogastralen Übergangs. Langenbecks Arch Chir Forumband 17?23

Sherman CA, Turrisi AT, Wallace MB, Reed CE (2002) Locally advanced esophageal cancer. Curr Treat Options Oncol 3:475?485

Shimosato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1:19?35

Sinn HP, Schmid H, Junkermann H et al. (1994) Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie. Geburtshilfe Frauenheilkd 54:552?558

Sulfaro S, Frustaci S, Volpe R et al. (1989) A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen. Cancer 64:994?1001

Thomas M, Rube C, Semik M et al. (1999) Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 17:1185

Urba SG, Orringer MB, Turrisi A et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305?313

Walsh TN, Noonan N, Hollywood D et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462?467

Yonemura Y, Kinoshita K, Fujimura T et al. (1996) Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients. Hepatogastroenterology 43:1260?1272